T‐cell epitope‐dependent immune response in inbred (C57BL/6J, SJL/J, and C3H/HeN) and transgenic P301S and Tg2576 mice

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Peptide Science

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/psc.2518PMID 23728915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease

  2013cited by this paper
• Evaluation of peptide adsorption-controlled liquid chromatography-tandem mass spectrometric (PAC-LC-MS/MS) method for simple and simultaneous quantitation of amyloid β 1-38, 1-40, 1-42 and 1-43 peptides in dog cerebrospinal fluid.

  2012cited by this paper
• Therapeutic potential of vaccines for Alzheimer's disease.

  2011cited by this paper
• Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials.

  2011cited by this paper
• Vaccination with M2e-Based Multiple Antigenic Peptides: Characterization of the B Cell Response and Protection Efficacy in Inbred and Outbred Mice

  2011cited by this paper
• Immunotherapy for Tauopathies

  2011cited by this paper
• Regulation of Anthrax Toxin-Specific Antibody Titers by Natural Killer T Cell-Derived IL-4 and IFNγ

  2011cited by this paper
• Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model

  2010cited by this paper
• Immunization therapy for Alzheimer disease: a comprehensive review of active immunization strategies.

  2010cited by this paper
• Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors.

  2009cited by this paper
• Towards an understanding of the adjuvant action of aluminium

  2009cited by this paper
• Tau-focused immunotherapy for Alzheimer's disease and related tauopathies.

  2009cited by this paper
• Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection

  2008cited by this paper
• Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.

  2008cited by this paper
• DNA epitope vaccine containing complement component C3d enhances anti-amyloid-beta antibody production and polarizes the immune response towards a Th2 phenotype.

  2008cited by this paper
• Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology

  2008cited by this paper
• Protective Immune Responses to a Recombinant Adenovirus Type 35 Tuberculosis Vaccine in Two Mouse Strains: CD4 and CD8 T-Cell Epitope Mapping and Role of Gamma Interferon

  2007cited by this paper
• Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements

  2007cited by this paper
• Peptide Vaccines of the HER-2/neu Dimerization Loop Are Effective in Inhibiting Mammary Tumor Growth In Vivo1

  2007cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007cited by this paper
• Design, Synthese und Untersuchung des Bindungsverhaltens von Inhibitoren der Interaktion von viralem Interleukin-6 mit dem Zytokinrezeptor gp130

  2007cited by this paper
• Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease.

  2006cited by this paper
• Genetic and environmental modifiers of Alzheimer's disease phenotypes in the mouse.

  2006cited by this paper
• Characterization of Phosphorylation Dependent Antibodies To Study the Phosphorylation Status of the Tau Protein

  2005cited by this paper
• β-Amyloid Is Different in Normal Aging and in Alzheimer Disease*

  2005cited by this paper
• Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria.

  2005cited by this paper
• beta-amyloid is different in normal aging and in Alzheimer disease.

  2005cited by this paper
• Mapping of Murine Th1 Helper T-Cell Epitopes of Mycolyl Transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis

  2003cited by this paper
• Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

  2003cited by this paper
• Importance of IgG2c isotype in the immune response to beta-amyloid in amyloid precursor protein/transgenic mice.

  2003cited by this paper
• Adjuvant-dependent modulation of T h 1 and T h 2 responses to immunization with b-amyloid

  2003cited by this paper
• Immunogenicity of Peptide-25 of Ag85B in Th1 development: role of IFN-gamma.

  2003cited by this paper
• Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease.

  2002cited by this paper
• Plasmodium vivax Promiscuous T-Helper Epitopes Defined and Evaluated as Linear Peptide Chimera Immunogens

  2002cited by this paper
• Passage of amyloid β protein antibody across the blood–brain barrier in a mouse model of Alzheimer’s disease

  2002cited by this paper
• Synthetic peptides as cancer vaccines.

  2002cited by this paper
• Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.

  2002cited by this paper
• Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning

  2002cited by this paper
• Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.

  2001cited by this paper
• Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease.

  1999cited by this paper
• Specificity of the T-cell responses in covalently linked peptides each comprising of a T helper epitope.

  1997cited by this paper
• Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.

  1997cited by this paper
• Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.

  1997cited by this paper
• Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain

  1995cited by this paper
• Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction

  1995cited by this paper
• Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

  1995cited by this paper
• Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

  1995cited by this paper
• Peptide vaccines incorporating a ‘promiscuous’ T‐cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity

  1993cited by this paper
• A novel, convenient, three-dimensional orthogonal strategy for solid-phase synthesis of cyclic peptides

  1993cited by this paper
• Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system.

  1991cited by this paper
• Identification of two promiscuous T cell epitopes from tetanus toxin

  1990cited by this paper
• Synthesis and biophysical characterization of engineered topographic immunogenic determinants with alpha alpha topology.

  1990cited by this paper
• Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans.

  1990cited by this paper

• A chimeric protein-based malaria vaccine candidate induces A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119 robust T cell responses against Plasmodium vivax MSP119

  2021cites this paper
• Emerging Promise of Immunotherapy for Alzheimer's Disease: A New Hope for the Development of Alzheimer's Vaccine.

  2020cites this paper
• A walk through tau therapeutic strategies

  2019cites this paper
• Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer’s disease and frontotemporal dementia

  2018cites this paper
• A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119

  2016cites this paper
• New progress in active immunotherapy targeting to amyloid beta

  2015cites this paper
• Immunogenicity and pharmacokinetics of short, proline-rich antimicrobial peptides.

  2015cites this paper
• Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease

  2014cites this paper
• First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

  2014cites this paper
• Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer’s Disease Like Tau Aggregation

  2014influential citation